Legal Representation
Attorney
Brian P. Gregg
USPTO Deadlines
Next Deadline
930 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-01-25)
Due Date
January 25, 2028
Grace Period Ends
July 25, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description |
|---|---|---|---|
| Jan 25, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Nov 9, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Nov 9, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 20, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 1, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 24, 2021 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Sep 24, 2021 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Sep 7, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 7, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 30, 2021 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Apr 12, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Apr 12, 2021 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
| Apr 12, 2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Apr 6, 2021 | ALIE | A | ASSIGNED TO LIE |
| Apr 6, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Apr 6, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jan 5, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 25, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Sep 25, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Sep 25, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sep 19, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 15, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jun 20, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Anti-itch ointments; anti-itch creams; Cultures of microorganisms for medical purposes; pharmaceutical preparations for skin care; medicated preparations for the treatment of skin conditions, namely, alopecia, dermatitis, eczema, psoriasis; dermatological pharmaceutical substances for the treatment of dermatological related diseases and disorders; medicated skin care preparations; mineral supplements to foodstuffs being mineral food supplements; dietary supplements; nutraceuticals for use as dietary supplements; vaccines; adjuvants for use with vaccines; vitamin preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005